These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35149000)

  • 1. Predominance of Staphylococcus Correlates with Wound Burden and Disease Activity in Dystrophic Epidermolysis Bullosa: A Prospective Case-Control Study.
    Reimer-Taschenbrecker A; Künstner A; Hirose M; Hübner S; Gewert S; Ibrahim S; Busch H; Has C
    J Invest Dermatol; 2022 Aug; 142(8):2117-2127.e8. PubMed ID: 35149000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Case Report of an Infant with Autosomal Recessive Dystrophic Epidermolysis Bullosa: COL7A1 Gene Mutations at C2005T and G7922A.
    Liu J; Wang L
    Acta Dermatovenerol Croat; 2021 Dec; 29(3):164-166. PubMed ID: 34990346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological and morphometric analysis of cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: a retrospective study.
    Filoni A; Cicco G; Lospalluti L; Maglietta A; Foti C; Annichiarico G; Resta L; Bonamonte D
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1707-1714. PubMed ID: 31692111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal study of wound healing status and bacterial colonisation of Staphylococcus aureus and Corynebacterium diphtheriae in epidermolysis bullosa patients.
    Fuentes I; Yubero MJ; Morandé P; Varela C; Oróstica K; Acevedo F; Rebolledo-Jaramillo B; Arancibia E; Porte L; Palisson F
    Int Wound J; 2023 Mar; 20(3):774-783. PubMed ID: 36787273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa.
    Tang JY; Marinkovich MP; Lucas E; Gorell E; Chiou A; Lu Y; Gillon J; Patel D; Rudin D
    Orphanet J Rare Dis; 2021 Apr; 16(1):175. PubMed ID: 33849616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for cutaneous dysbiosis in dystrophic epidermolysis bullosa.
    Bar J; Sarig O; Lotan-Pompan M; Dassa B; Miodovnik M; Weinberger A; Sprecher E; Segal E; Samuelov L
    Clin Exp Dermatol; 2021 Oct; 46(7):1223-1229. PubMed ID: 33682945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of junctional epidermolysis bullosa intermediate with collagen XVII deficiency treated with dupilumab.
    Zhang L; Wang S; Chen Q; Xiang L
    J Dermatolog Treat; 2023 Dec; 34(1):2253943. PubMed ID: 37968922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oral microbiome in children with dystrophic recessive epidermolysis bullosa].
    Korolenkova MV; Poberezhnaya AA; Dmitrieva NA
    Stomatologiia (Mosk); 2022; 101(1):46-52. PubMed ID: 35184533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-reported outcomes and quality of life in recessive dystrophic epidermolysis bullosa: A global cross-sectional survey.
    Eng VA; Solis DC; Gorell ES; Choi S; Nazaroff J; Li S; de Souza MP; Murrell DF; Marinkovich MP; Tang JY
    J Am Acad Dermatol; 2021 Nov; 85(5):1161-1167. PubMed ID: 32199895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dominant dystrophic epidermolysis bullosa with congenital absence of skin and brachydactyly of the great toes.
    Sawka E; Funk T
    Pediatr Dermatol; 2021 Sep; 38(5):1251-1254. PubMed ID: 34338359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired secretory immunity in dystrophic epidermolysis bullosa.
    Sweet SP; Ballsdon AE; Harris JC; Roberts GJ; Challacombe SJ
    Oral Microbiol Immunol; 1999 Oct; 14(5):316-20. PubMed ID: 10551159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations.
    McGrath JA; Ashton GH; Mellerio JE; Salas-Alanis JC; Swensson O; McMillan JR; Eady RA
    J Invest Dermatol; 1999 Sep; 113(3):314-21. PubMed ID: 10469327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human skin collagenase in recessive dystrophic epidermolysis bullosa. Purification of a mutant enzyme from fibroblast cultures.
    Stricklin GP; Welgus HG; Bauer EA
    J Clin Invest; 1982 Jun; 69(6):1373-83. PubMed ID: 6282934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin expression of metalloproteinases and tissue inhibitor of metalloproteinases in sibling patients with recessive dystrophic epidermolysis and intrafamilial phenotypic variation.
    Bodemer C; Tchen SI; Ghomrasseni S; Séguier S; Gaultier F; Fraitag S; de Prost Y; Godeau G
    J Invest Dermatol; 2003 Aug; 121(2):273-9. PubMed ID: 12880418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gluten-sensitive enteropathy in recessive dystrophic epidermolysis bullosa.
    Sacedón R; de Arriba MC; Martínez-Santamaría L; Maseda R; Herráiz-Gil S; Jiménez E; Rosales I; Quintana L; Illera N; García M; Butta N; Fernández-Bello I; Lwin SM; Fernández-Arquero M; León C; McGrath JA; Vicente MÁ; Del Río M; de Lucas R; Sánchez-Ramón S; Escámez MJ
    Br J Dermatol; 2023 Nov; 189(6):774-776. PubMed ID: 37655918
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa.
    Wagner JE; Ishida-Yamamoto A; McGrath JA; Hordinsky M; Keene DR; Woodley DT; Chen M; Riddle MJ; Osborn MJ; Lund T; Dolan M; Blazar BR; Tolar J
    N Engl J Med; 2010 Aug; 363(7):629-39. PubMed ID: 20818854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural variations in anchoring fibrils in dystrophic epidermolysis bullosa: correlation with type VII collagen expression.
    McGrath JA; Ishida-Yamamoto A; O'Grady A; Leigh IM; Eady RA
    J Invest Dermatol; 1993 Apr; 100(4):366-72. PubMed ID: 8454899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-reported outcomes and quality of life in dominant dystrophic epidermolysis bullosa: A global cross-sectional survey.
    Fulchand S; Harris N; Li S; Barriga M; Gorell E; De Souza M; Murrell D; Marinkovich MP; Krishna Yenamandra V; Tang JY
    Pediatr Dermatol; 2021 Sep; 38(5):1198-1201. PubMed ID: 34515355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participatory co-design of patient-reported outcome indicators and N-of-1 evaluation of a dressing glove for Epidermolysis bullosa.
    Graham T; Sooriah S; Box R; Gage H; Williams P; Clemett V; Grocott P
    J Wound Care; 2020 Dec; 29(12):751-762. PubMed ID: 33320744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identical COL71A1 heterozygous mutations resulting in different dystrophic epidermolysis bullosa phenotypes.
    Knöpfel N; Noguera-Morel L; Hernández-Martin A; García-Martin A; García M; Mencía Á; Pedrero RM; de Lucas R; Escámez MJ; Torrelo A
    Pediatr Dermatol; 2018 Mar; 35(2):e94-e98. PubMed ID: 29272047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.